Home > Boards > US Listed > Medical - Drugs >

Tekmira Pharmaceuticals Corporation (TKMR)

TKMR RSS Feed
Add TKMR Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator nanopatent, KarinCA
Search This Board:
Last Post: 7/29/2014 7:30:12 PM - Followers: 25 - Board type: Free - Posts Today: 0

Tekmira Pharmaceuticals Corporation

 

(TSE:TKM, or US TKMR) 

 

 

http://www.tekmirapharm.com

 

 

 


 

 

 

Company Information:

100 - 8900 Glenlyon Parkway
Burnaby, British Columbia
Canada V5J 5J8

Telephone: 604.419.3200
Fax: 604.419.3201

 

As the fields of genetics, medicine and therapeutics continue to converge, the management of illness at its genetic source by silencing genes via RNA interference (RNAi) holds the very real potential to revolutionize treatment on a scale not seen in decades. Tekmira is one of a handful of biotech companies around the world working to exploit the potential of RNAi to treat disease. And it is from among these unique companies that the next wave of therapeutic breakthroughs will emerge.

 

Tekmira is uniquely equipped to become a leading force in the field. Guided by a cohesive vision, the company possesses leading technology capabilities and a solid intellectual property portfolio in the area of lipid-based nucleic acid delivery, known as SNALP (Stable Nucleic Acid Lipid Particles) to deliver siRNAs (small interfering RNAs) as well as other oligonucleotides in the treatment of disease.

With one RNAi drug candidate in clinical development and another in late preclinical development,  plus a pipeline of up to five additional targets made possible through an agreement with RNAi leader Alnylam, Tekmira is well positioned to aggressively advance its product development strategy. In addition to Alnylam, Roche, Merck and Regulus all have access to Tekmira's technology in the delivery of siRNAs and microRNAs.

Finally, broad manufacturing capabilities and a strong capital position permit the company to move forward decisively and build a solid base for both near and longer term growth.

 

Management:   http://www.tekmirapharm.com/Corporate/Management.asp

 

 

Important Company Highlights: 

SNALP
Tekmira's siRNA delivery technology platform is termed SNALP for "stable nucleic acid-lipid particles". SNALP are specialized lipid nanoparticles that fully encapsulate and systemically deliver a variety of nucleic acid molecules such as siRNA. Pre-clinical studies have shown them to be effective in delivering the drug to target organs and into cells where the nucleic acid-based drug can carry out its desired effect while minimizing systemic toxicity.

 

SNALP technology relies on something called the "enhanced permeability and retention effect", which occurs because these nucleic acid-containing particles have a long circulation time in the blood, resulting in increased accumulation at sites of vascular leak such as those found at sites of tumor cell growth, infection or inflammation. Once at the target site, cells take up the SNALP through endocytosis and the nucleic acid payload is delivered inside the cell resulting in unparalleled potency.

 

 

********************************************************************************************

 

Recent News:  

 

http://tmx.quotemedia.com/news.php?qm_symbol=TKM#page1


http://investor.tekmirapharm.com/releases.cfm

http://finance.yahoo.com/q?s=tkmr&ql=1 

 

http://www.marketwatch.com/investing/stock/tkmr/news
 

********************************************************************************************

 

 

 

Filings:  http://www.tekmirapharm.com/Investors/Shareholder_Reports.asp

 

http://www.sec.gov/cgi-bin/browse-edgar?company=&match=&CIK=0001447028&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

 

 

 

 

Links of importance for those that trade Canadian stocks:

 

Sedar   http://www.sedar.com/homepage_en.htm

 

TMX.  http://www.tmx.com/

 

TMXmoney   http://www.tmxmoney.com/en/index.html

 

CNW Group Newswire   http://www.cnxmarketlink.com/en/index.cgi

 

Canadian Insider 

http://canadianinsider.com/coReport/allTransactions.php?ticker=tkm


Currency Converter:  http://www.bankofcanada.ca/en/rates/converter.html

 

 

Transfer Agent:

CIBC Mellon Trust,
Suite 1600, The Oceanic Plaza,
1066 West Hastings Street,
Vancouver, BC V6E 3X1

 

Share Structure:

Outstanding Shares

51,600,000 as of Sept 30, 2009

 



Investor Relations:

Ian Mortimer
Executive Vice President, Finance and Chief Financial Officer
Telephone: 604.419.3200
Fax: 604.419.3201

Adam Peeler
Investor Relations
The Equicom Group
Telephone: 416.815.0700 x 225 

 

 

 

 

CHART is for Canadian ticker.  Remember to adjust for exchange rate.

Currency Converter: 
http://www.bankofcanada.ca/en/rates/converter.html


 

 

 

 

All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

 

Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn't a sign of endorsement.

 

Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:
http://investorshub.advfn.com/boards/complex_terms.asp

 

 

 

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
TKMR
Current Price
Volume:
Bid Ask Day's Range
Wiki
Option Chain for TKMR
TKMR News: Current Report Filing (8-k) 07/21/2014 12:40:16 PM
TKMR News: Tekmira Provides Update on TKM-Ebola Phase I Clinical Hold 07/21/2014 12:19:28 PM
TKMR News: Tekmira Receives $1.5 Million Milestone Payment 07/09/2014 07:00:00 PM
TKMR News: Current Report Filing (8-k) 07/03/2014 06:02:20 AM
TKMR News: Tekmira Receives Notice of Clinical Hold for TKM-Ebola Phase I Clinical Trial 07/03/2014 03:15:00 AM
PostSubject
#740   I suspect she's gonna fly - Just as nowwhat2 07/29/14 07:30:12 PM
#739   If I was king or even Obama, this nanopatent 07/29/14 03:23:38 PM
#738   I doubt it, at least not thru official sources. nanopatent 07/29/14 02:44:47 PM
#737   Wouldn't hurt. nanopatent 07/29/14 02:43:20 PM
#736   Ebola Virus Now Threatens 21 Million People In nanopatent 07/29/14 02:38:24 PM
#735   you want them to build toilets? brigar6 07/29/14 02:12:54 PM
#733   Nanopatent Once released is released. Will Brantly get some? I'm time. Echo Echo20 07/29/14 02:04:14 PM
#732   The FDA impedes, not passes. nanopatent 07/29/14 01:33:47 PM
#731   Nanopatent Is today's rise due FDA passing TKMR Ebola? Echo20 Echo20 07/29/14 12:45:52 PM
#730   It has among the highest prevalence rates of nanopatent 07/29/14 12:40:10 PM
#729   off the 10.70 ascend tri. Nice here theme developing ~S.B.A.~ 07/29/14 11:24:49 AM
#728   TKMR TKMR could be tested in Africa. Echo20 Echo20 07/29/14 10:55:27 AM
#727   Why Ebola reaching Nigeria’s largest city is a Double_Bagel 07/29/14 09:18:42 AM
#726   FORT WORTH, Texas (AP) — Kent Brantly always Echo20 07/28/14 10:14:50 PM
#725   Nanopatent I vote that Dr. Brantly gets put on Echo20 07/28/14 01:35:39 AM
#724   There is no known cure for the highly nanopatent 07/27/14 08:56:02 PM
#723   Ebola kills Liberian doctor, 2 Americans infected Echo20 07/27/14 08:00:38 PM
#722   If Tekmira relies on the US FDA, hell nanopatent 07/27/14 10:48:28 AM
#721   U.S. doctor contracts Ebola in Liberia Echo20 07/27/14 06:08:47 AM
#720   Reason why I hate trading Tekmira. 3 of chmcnfunds 07/25/14 04:48:08 PM
#719   Tekmira intentionally held back the steroids to get nanopatent 07/25/14 04:00:19 PM
#718   by Q4, 2014 nanopatent 07/25/14 03:53:26 PM
#717   Tekmira Provides Update on TKM-Ebola Phase I Clinical KarinCA 07/25/14 03:50:45 PM
#716   If this takes longer than a week to nanopatent 07/25/14 03:16:36 PM
#715   Nice source for following the issues: chmcnfunds 07/25/14 02:12:41 PM
#714   Liberian man tests positive for Ebola in Nigeria's Lagos chmcnfunds 07/25/14 02:00:27 PM
#713   The FDA is obviously very interested since they KarinCA 07/25/14 01:25:01 PM
#712   If Ebola was in LA the FDA MIGHT nanopatent 07/25/14 12:10:04 PM
#711   Ebola outbreak -- Could the WHO approach the Double_Bagel 07/25/14 12:04:04 PM
#710   Ebola Kills Liberian in Lagos in Nigeria’s First chmcnfunds 07/25/14 11:27:15 AM
#709   For many years, the Zaire species of Ebola chmcnfunds 07/25/14 11:11:21 AM
#708   First Ebola victim in Sierra Leone capital on chmcnfunds 07/25/14 10:16:36 AM
#706   Science 25 July 2014: chmcnfunds 07/24/14 03:53:48 PM
#705   One analyst sees the value: chmcnfunds 07/24/14 03:42:52 PM
#704   And Tekmira has the solution but because it nanopatent 07/24/14 03:02:46 PM
#703   Liberian Man Tested For Ebola In World's Fourth chmcnfunds 07/24/14 02:15:02 PM
#702   It's quite a responsibility! ;-) nanopatent 07/24/14 09:50:38 AM
#700   Nanopatent, You are now head moderator for the most Echo20 07/23/14 10:47:02 PM
#699   Nanopatent Great Post. Echo20 07/23/14 10:40:50 PM
#698   Sierra Leone's Chief Ebola Doctor Contracts the Virus ] Echo20 07/23/14 10:36:30 PM
#697   This should be the last Ebola outbreak without nanopatent 07/23/14 12:46:53 PM
#696   Tekmira Pharmaceuticals: Is The Clinical Hold Sell-Off A nanopatent 07/22/14 10:17:34 AM
#695   Tekmira Provides Update on TKM-Ebola Phase I Clinical Hold KarinCA 07/21/14 02:11:10 PM
#694   Lassa fever or Lassa hemorrhagic fever (LHF) is an acute viral hemorrhagic fever Echo20 07/20/14 02:48:54 PM
#693   Ebola May Have Been Smoldering For Years, Study nanopatent 07/20/14 10:26:12 AM
#692   Nice.....because that $10 dollar level could put on nowwhat2 07/18/14 10:30:42 PM
#691   West African Villagers Fear Ebola Will Escape From Echo20 07/17/14 10:07:41 PM
#690   I put a toe in the water today. KarinCA 07/17/14 02:29:00 PM
#689   Global Insider Echo20 07/17/14 08:41:34 AM
#688   Ebola crisis in West Africa deepens; 500+ dead Echo20 07/14/14 04:47:03 PM
PostSubject